LAB vs PPL · rev $174.4M vs P/E 22, rev $8.46B
Standard Biotools Inc (LAB) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
LAB currently screens at market cap $317.1M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the LAB and PPL stock pages for the full models.
Not investment advice.